| 000 | 01056 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516104210.0 | ||
| 264 | 0 | _c20130115 | |
| 008 | 201301s 0 0 eng d | ||
| 022 | _a2567-5761 | ||
| 024 | 7 |
_a10.5482/HAMO-12-05-0009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWurster, T | |
| 245 | 0 | 0 |
_aAtopaxar. A novel player in antiplatelet therapy? _h[electronic resource] |
| 260 |
_bHamostaseologie _c2012 |
||
| 300 |
_a228-33 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aEvidence-Based Medicine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImines _xadministration & dosage |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aPyridines _xadministration & dosage |
| 650 | 0 | 4 |
_aReceptors, Thrombin _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aThrombosis _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMay, A E | |
| 773 | 0 |
_tHamostaseologie _gvol. 32 _gno. 3 _gp. 228-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5482/HAMO-12-05-0009 _zAvailable from publisher's website |
| 999 |
_c21996777 _d21996777 |
||